Annual Net Income
-$6.66 M
+$604.40 K+8.31%
31 August 2023
Summary:
Lexaria Bioscience annual net profit is currently -$6.66 million, with the most recent change of +$604.40 thousand (+8.31%) on 31 August 2023. During the last 3 years, it has fallen by -$2.64 million (-65.51%). LEXX annual net income is now -8704.36% below its all-time high of -$75.70 thousand, reached on 31 October 2005.LEXX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.78 M
-$1.13 M-174.32%
31 May 2024
Summary:
Lexaria Bioscience quarterly net profit is currently -$1.78 million, with the most recent change of -$1.13 million (-174.32%) on 31 May 2024. Over the past year, it has dropped by -$542.40 thousand (-43.77%). LEXX quarterly net income is now -351.69% below its all-time high of $707.90 thousand, reached on 31 October 2007.LEXX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$4.85 M
+$589.80 K+10.84%
31 May 2024
Summary:
Lexaria Bioscience TTM net profit is currently -$4.85 million, with the most recent change of +$589.80 thousand (+10.84%) on 31 May 2024. Over the past year, it has increased by +$1.81 million (+27.23%). LEXX TTM net income is now -9877.82% below its all-time high of $49.60 thousand, reached on 31 July 2008.LEXX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -43.8% | +27.2% |
| 3 y3 years | -65.5% | -51.2% | -20.4% |
| 5 y5 years | -62.6% | -65.3% | -18.3% |
LEXX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.5% | +8.3% | -174.3% | +25.2% | -20.4% | +33.3% |
| 5 y | 5 years | -69.4% | +8.3% | -540.9% | +30.3% | -95.6% | +33.3% |
| alltime | all time | -8704.4% | +8.3% | -351.7% | +48.0% | -9877.8% | +33.3% |
Lexaria Bioscience Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2024 | - | -$1.78 M(+174.3%) | -$4.85 M(-10.8%) |
| Feb 2024 | - | -$649.50 K(-44.9%) | -$5.44 M(-10.7%) |
| Nov 2023 | - | -$1.18 M(-4.8%) | -$6.09 M(-8.7%) |
| Aug 2023 | -$6.66 M(-8.3%) | -$1.24 M(-47.7%) | -$6.66 M(-3.3%) |
| May 2023 | - | -$2.37 M(+82.7%) | -$6.89 M(-0.2%) |
| Feb 2023 | - | -$1.30 M(-26.1%) | -$6.90 M(-1.8%) |
| Nov 2022 | - | -$1.76 M(+19.7%) | -$7.03 M(-3.3%) |
| Aug 2022 | -$7.27 M(+80.5%) | -$1.47 M(-38.4%) | -$7.27 M(+4.1%) |
| May 2022 | - | -$2.38 M(+67.1%) | -$6.98 M(-2.4%) |
| Feb 2022 | - | -$1.43 M(-28.5%) | -$7.15 M(+34.4%) |
| Nov 2021 | - | -$1.99 M(+69.2%) | -$5.32 M(+32.2%) |
| Aug 2021 | -$4.03 M(+2.4%) | -$1.18 M(-53.9%) | -$4.03 M(+9.6%) |
| May 2021 | - | -$2.56 M(-732.8%) | -$3.67 M(+48.2%) |
| Feb 2021 | - | $404.10 K(-158.1%) | -$2.48 M(-35.3%) |
| Nov 2020 | - | -$696.00 K(-15.7%) | -$3.83 M(-5.2%) |
| Aug 2020 | -$3.93 M(-4.0%) | -$825.60 K(-39.4%) | -$4.04 M(-5.9%) |
| May 2020 | - | -$1.36 M(+43.3%) | -$4.30 M(+4.6%) |
| Feb 2020 | - | -$950.30 K(+4.7%) | -$4.11 M(-4.6%) |
| Nov 2019 | - | -$907.30 K(-15.9%) | -$4.31 M(+5.0%) |
| Aug 2019 | -$4.10 M(-37.9%) | -$1.08 M(-8.0%) | -$4.10 M(-3.3%) |
| May 2019 | - | -$1.17 M(+2.1%) | -$4.24 M(-34.7%) |
| Feb 2019 | - | -$1.15 M(+63.7%) | -$6.49 M(-3.4%) |
| Nov 2018 | - | -$701.40 K(-42.4%) | -$6.72 M(+1.9%) |
| Aug 2018 | -$6.60 M(+253.0%) | -$1.22 M(-64.5%) | -$6.60 M(+8.7%) |
| May 2018 | - | -$3.42 M(+148.5%) | -$6.07 M(+103.4%) |
| Feb 2018 | - | -$1.38 M(+138.2%) | -$2.98 M(+45.3%) |
| Nov 2017 | - | -$578.70 K(-15.8%) | -$2.05 M(+9.8%) |
| Aug 2017 | -$1.87 M(+53.9%) | -$686.90 K(+102.6%) | -$1.87 M(+24.9%) |
| May 2017 | - | -$339.10 K(-24.3%) | -$1.50 M(+5.7%) |
| Feb 2017 | - | -$447.80 K(+13.3%) | -$1.42 M(+15.3%) |
| Nov 2016 | - | -$395.40 K(+25.8%) | -$1.23 M(+1.1%) |
| Aug 2016 | -$1.21 M(-31.4%) | -$314.40 K(+21.9%) | -$1.21 M(-14.2%) |
| May 2016 | - | -$258.00 K(-0.7%) | -$1.42 M(-12.9%) |
| Feb 2016 | - | -$259.80 K(-32.1%) | -$1.63 M(-10.9%) |
| Nov 2015 | - | -$382.50 K(-25.8%) | -$1.82 M(+2.0%) |
| Aug 2015 | -$1.77 M | -$515.80 K(+10.3%) | -$1.79 M(-2.8%) |
| May 2015 | - | -$467.50 K(+1.9%) | -$1.84 M(-1.4%) |
| Feb 2015 | - | -$458.60 K(+32.1%) | -$1.87 M(+32.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2014 | - | -$347.20 K(-38.9%) | -$1.41 M(+9.2%) |
| Aug 2014 | -$3.26 M(+848.1%) | - | - |
| July 2014 | - | -$568.00 K(+15.1%) | -$1.29 M(+65.5%) |
| Apr 2014 | - | -$493.30 K(+384.1%) | -$779.20 K(+133.7%) |
| Jan 2014 | - | -$101.90 K(-19.3%) | -$333.40 K(-3.0%) |
| Oct 2013 | -$343.60 K(+36.6%) | -$126.30 K(+118.9%) | -$343.60 K(+84.8%) |
| July 2013 | - | -$57.70 K(+21.5%) | -$185.90 K(+209.3%) |
| Apr 2013 | - | -$47.50 K(-57.6%) | -$60.10 K(-75.4%) |
| Jan 2013 | - | -$112.10 K(-457.0%) | -$244.70 K(-2.7%) |
| Oct 2012 | -$251.50 K(-53.3%) | $31.40 K(-53.9%) | -$251.50 K(-10.9%) |
| July 2012 | - | $68.10 K(-129.3%) | -$282.20 K(-53.2%) |
| Apr 2012 | - | -$232.10 K(+95.2%) | -$603.30 K(+14.5%) |
| Jan 2012 | - | -$118.90 K(<-9900.0%) | -$527.00 K(-2.1%) |
| Oct 2011 | -$538.20 K(-2.6%) | $700.00(-100.3%) | -$538.30 K(-12.7%) |
| July 2011 | - | -$253.00 K(+62.4%) | -$616.70 K(+56.9%) |
| Apr 2011 | - | -$155.80 K(+19.7%) | -$393.10 K(-1.7%) |
| Jan 2011 | - | -$130.20 K(+67.6%) | -$399.80 K(-27.6%) |
| Oct 2010 | -$552.50 K(-26.7%) | -$77.70 K(+164.3%) | -$552.40 K(-14.2%) |
| July 2010 | - | -$29.40 K(-81.9%) | -$643.90 K(-21.7%) |
| Apr 2010 | - | -$162.50 K(-42.5%) | -$822.80 K(-5.8%) |
| Jan 2010 | - | -$282.80 K(+67.1%) | -$873.60 K(+15.9%) |
| Oct 2009 | -$753.60 K(-23.0%) | -$169.20 K(-18.8%) | -$753.70 K(-16.7%) |
| July 2009 | - | -$208.30 K(-2.3%) | -$904.70 K(+19.7%) |
| Apr 2009 | - | -$213.30 K(+30.9%) | -$755.60 K(-29.8%) |
| Jan 2009 | - | -$162.90 K(-49.1%) | -$1.08 M(+9.9%) |
| Oct 2008 | -$978.50 K(-7.3%) | -$320.20 K(+440.9%) | -$978.50 K(-2072.8%) |
| July 2008 | - | -$59.20 K(-88.9%) | $49.60 K(-104.8%) |
| Apr 2008 | - | -$533.30 K(+710.5%) | -$1.03 M(+18.7%) |
| Jan 2008 | - | -$65.80 K(-109.3%) | -$868.50 K(-17.7%) |
| Oct 2007 | -$1.06 M(+107.7%) | $707.90 K(-162.1%) | -$1.06 M(-51.3%) |
| July 2007 | - | -$1.14 M(+207.0%) | -$2.17 M(+100.6%) |
| Apr 2007 | - | -$371.20 K(+46.7%) | -$1.08 M(+46.1%) |
| Jan 2007 | - | -$253.10 K(-37.4%) | -$739.70 K(+43.5%) |
| Oct 2006 | -$508.30 K(+571.5%) | -$404.40 K(+673.2%) | -$515.60 K(+363.7%) |
| July 2006 | - | -$52.30 K(+74.9%) | -$111.20 K(+88.8%) |
| Apr 2006 | - | -$29.90 K(+3.1%) | -$58.90 K(+103.1%) |
| Jan 2006 | - | -$29.00 K | -$29.00 K |
| Oct 2005 | -$75.70 K | - | - |
FAQ
- What is Lexaria Bioscience annual net profit?
- What is the all time high annual net income for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly net profit?
- What is the all time high quarterly net income for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly net income year-on-year change?
- What is Lexaria Bioscience TTM net profit?
- What is the all time high TTM net income for Lexaria Bioscience?
- What is Lexaria Bioscience TTM net income year-on-year change?
What is Lexaria Bioscience annual net profit?
The current annual net income of LEXX is -$6.66 M
What is the all time high annual net income for Lexaria Bioscience?
Lexaria Bioscience all-time high annual net profit is -$75.70 K
What is Lexaria Bioscience quarterly net profit?
The current quarterly net income of LEXX is -$1.78 M
What is the all time high quarterly net income for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly net profit is $707.90 K
What is Lexaria Bioscience quarterly net income year-on-year change?
Over the past year, LEXX quarterly net profit has changed by -$542.40 K (-43.77%)
What is Lexaria Bioscience TTM net profit?
The current TTM net income of LEXX is -$4.85 M
What is the all time high TTM net income for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM net profit is $49.60 K
What is Lexaria Bioscience TTM net income year-on-year change?
Over the past year, LEXX TTM net profit has changed by +$1.81 M (+27.23%)